3D Spine Matrix Biotechnology

Austria
Krems an der Donau, Lower Austria, Austria, A-3500

Company profile

3D Spine Matrix Biotechnology company profile

3D Spine Matrix researches, develops and commercializes a novel proprietary biological technology that is capable of restoring the function of damaged cartilage through the reconstruction and regeneration of structural tissue. The company`s matrix technology uses biological material that ensures structurally sound cartilage in the human body like spinal disc implants, menisci and ligaments and targets to support stem cells and 3D Bio Printing/Plotting applications. Biological restructuring and regeneration of cartilage is one of the ultimate goals of orthopedics. 3D Spine Matrix offers a sustainable solution in treating the wide ranging and ever-increasing problem of cartilage degeneration, especially to develop a novel technology that uses highly compressed collagen to produce a nucleus implant with cartilage-like hydro gel.

Business identity

Contact email
[email protected]
Phone number
+4367761551235
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2016-02-19

Headquarters

Postal code
A-3500
Country code
AT
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$66,338
Last funding
Seed / $66,338 / 2018-01-02
Last equity funding
Seed / $66,338
Founders
1

Founders and investors

Founders

Axel Krabler